Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126665311 | 12666531 | 1 | I | 20111122 | 20130325 | 20160819 | 20160819 | EXP | BE-ROCHE-1815906 | ROCHE | 74.44 | YR | M | Y | 0.00000 | 20160819 | MD | BE | BE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126665311 | 12666531 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
126665311 | 12666531 | 2 | SS | 5-FU | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
126665311 | 12666531 | 3 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126665311 | 12666531 | 1 | Colorectal cancer metastatic |
126665311 | 12666531 | 2 | Colorectal cancer metastatic |
126665311 | 12666531 | 3 | Colorectal cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126665311 | 12666531 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126665311 | 12666531 | Anaemia | |
126665311 | 12666531 | Hemiplegia | |
126665311 | 12666531 | Hypertension | |
126665311 | 12666531 | Proteinuria | |
126665311 | 12666531 | Rash erythematous | |
126665311 | 12666531 | Speech disorder | |
126665311 | 12666531 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |